Predicción y previsión de precio de Evommune Inc (EVMN)EVMNEvommune Inc

Alphio's EVMN stock price prediction model matches the current Evommune Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.75 (+0.23%). The 1-week path is $6.66 (-1.01%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Evommune, Inc. (EVMN) is not a good buy right now due to its current price of $5.10, which is significantly lower than the analyst price targets, indicating a lack of confidence in the stock's near-term recovery. The RSI is at a low 20.734, suggesting that the stock is oversold, but this does not guarantee a rebound. The company has faced substantial losses, with a net income of -32,246,000 USD in Q2 2026, and a staggering year-to-date change of -70.54%. The main risk is the company's recent drug trial failures, which have led to a negative sentiment shift among investors and a significant drop in share price.

Evommune Inc (EVMN) last closed at $6.73, losing -1.17%. These facts feed the 1-day and 1-week EVMN price prediction above.